Redox-triggered mitoxantrone prodrug micelles for overcoming multidrug-resistant breast cancer

References

• Yan Y, Ochs CJ, Such GK, et al. Bypassing multidrug resistance in cancer cells with biodegradable polymer capsules. Adv Mater. 2010;22:5398–5403.
   PubMed Web of Science ®Google Scholar
• Aller SG, Yu J, Ward A, et al. Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding. Science. 2009;323:1718–1722.
   PubMed Web of Science ®Google Scholar
• Szakacs G, Annereau JP, Lababidi S, et al. Predicting drug sensitivity and resistance: profiling ABC transporter genes in cancer cells. Cancer Cell. 2004;6:129–137.
   PubMed Web of Science ®Google Scholar
• Fletcher JI, Haber M, Henderson MJ, et al. ABC transporters in cancer: more than just drug efflux pumps. Nat Rev Cancer. 2010;10:147–156.
   PubMed Web of Science ®Google Scholar
• Tang J, Fu Q, Wang Y, et al. Vitamin E reverses multidrug resistance in vitro and in vivo. Cancer Lett. 2013;336:149–157.
   PubMed Web of Science ®Google Scholar
• Mu L, Seow PH. Application of TPGS in polymeric nanoparticulate drug delivery system. Colloids Surf B Biointerfaces. 2006;47:90–97.
   PubMed Web of Science ®Google Scholar
• Shen F, Bailey BJ, Chu S, et al. Dynamic assessment of mitoxantrone resistance and modulation of multidrug resistance by valspodar (PSC833) in multidrug resistance human cancer cells. J Pharmacol Exp Ther. 2009;330:423–429.
   PubMed Web of Science ®Google Scholar
• Diah SK, Smitherman PK, Aldridge J, et al. Resistance to mitoxantrone in multidrug-resistant MCF7 breast cancer cells: evaluation of mitoxantrone transport and the role of multidrug resistance protein family proteins. Cancer Res. 2001;61:5461–5467.
   PubMed Web of Science ®Google Scholar
• Chang RS, Kim J, Lee HY, et al. Reduced dose-limiting toxicity of intraperitoneal mitoxantrone chemotherapy using cardiolipin-based anionic liposomes. Nanomedicine. 2010;6:769–776.
   PubMed Web of Science ®Google Scholar
• Toh TB, Lee DK, Hou W, et al. Nanodiamond-mitoxantrone complexes enhance drug retention in chemoresistant breast cancer cells. Mol Pharm. 2014;11:2683–2691.
   PubMed Web of Science ®Google Scholar
• Cao N, Feng SS. Doxorubicin conjugated to D-alpha-tocopheryl polyethylene glycol 1000 succinate (TPGS): conjugation chemistry, characterization, in vitro and in vivo evaluation. Biomaterials. 2008;29:3856–3865.
   PubMed Web of Science ®Google Scholar
• Bao Y, Guo Y, Zhuang X, et al. D-alpha-tocopherol polyethylene glycol succinate-based redox-sensitive paclitaxel prodrug for overcoming multidrug resistance in cancer cells. Mol Pharm. 2014;11:3196–3209.
   PubMed Web of Science ®Google Scholar
• Qiao H, Sun M, Su Z, et al. Kidney-specific drug delivery system for renal fibrosis based on coordination-driven assembly of catechol-derived chitosan. Biomaterials. 2014;35:7157–7171.
   PubMed Web of Science ®Google Scholar
• Sun Y, Kaplan JA, Shieh A, et al. Self-assembly of a 5-fluorouracil-dipeptide hydrogel. Chem Commun (Camb). 2016;52:5254–5257.
   PubMed Web of Science ®Google Scholar
• Shi Q, Zhang L, Liu M, et al. Reversion of multidrug resistance by a pH-responsive cyclodextrin-derived nanomedicine in drug resistant cancer cells. Biomaterials. 2015;67:169–182.
   PubMed Web of Science ®Google Scholar
• Qiao H, Li J, Wang Y, et al. Synthesis and characterization of multi-functional linear-dendritic block copolymer for intracellular delivery of antitumor drugs. Int J Pharm. 2013;452:363–373.
   PubMed Web of Science ®Google Scholar
• Wang X, Zhen X, Wang J, et al. Doxorubicin delivery to 3D multicellular spheroids and tumors based on boronic acid-rich chitosan nanoparticles. Biomaterials. 2013;34:4667–4679.
   PubMed Web of Science ®Google Scholar
• Wang AT, Liang DS, Liu YJ, et al. Roles of ligand and TPGS of micelles in regulating internalization, penetration and accumulation against sensitive or resistant tumor and therapy for multidrug resistant tumors. Biomaterials. 2015;53:160–172.
   PubMed Web of Science ®Google Scholar
• Sheng Y, You Y, Chen Y. Dual-targeting hybrid peptide-conjugated doxorubicin for drug resistance reversal in breast cancer. Int J Pharm. 2016;512:1–13.
   PubMed Web of Science ®Google Scholar
• Li J, Huo M, Wang J, et al. Redox-sensitive micelles self-assembled from amphiphilic hyaluronic acid-deoxycholic acid conjugates for targeted intracellular delivery of paclitaxel. Biomaterials. 2012;33:2310–2320.
   PubMed Web of Science ®Google Scholar
• Hao T, Chen D, Liu K, et al. Micelles of d-alpha-tocopheryl polyethylene glycol 2000 succinate (TPGS 2K) for doxorubicin delivery with reversal of multidrug resistance. ACS Appl Mater Interf. 2015;7:18064–18075.
   PubMed Web of Science ®Google Scholar
• Jiang T, Sun W, Zhu Q, et al. Furin-mediated sequential delivery of anticancer cytokine and small-molecule drug shuttled by graphene. Adv Mater. 2015;27:1021–1028.
   PubMed Web of Science ®Google Scholar
• Mohan P, Rapoport N. Doxorubicin as a molecular nanotheranostic agent: effect of doxorubicin encapsulation in micelles or nanoemulsions on the ultrasound-mediated intracellular delivery and nuclear trafficking. Mol Pharm. 2010;7:1959–1973.
   PubMed Web of Science ®Google Scholar
• Oliveira MS, Aryasomayajula B, Pattni B, et al. Solid lipid nanoparticles co-loaded with doxorubicin and alpha-tocopherol succinate are effective against drug-resistant cancer cells in monolayer and 3-D spheroid cancer cell models. Int J Pharm. 2016;512:292–300.
   PubMed Web of Science ®Google Scholar
• Danhier F, Kouhe TT, Duhem N, et al. Vitamin E-based micelles enhance the anticancer activity of doxorubicin. Int J Pharm. 2014;476:9–15.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Tozzi F, Chen J, et al. Intracellular ATP levels are a pivotal determinant of chemoresistance in colon cancer cells. Cancer Res. 2012;72:304–314.
   PubMed Web of Science ®Google Scholar
• Liu JN, Bu W, Pan LM, et al. Simultaneous nuclear imaging and intranuclear drug delivery by nuclear-targeted multifunctional upconversion nanoprobes. Biomaterials. 2012;33:7282–7290.
   PubMed Web of Science ®Google Scholar
• Liu P, Qin L, Wang Q, et al. cRGD-functionalized mPEG–PLGA–PLL nanoparticles for imaging and therapy of breast cancer. Biomaterials. 2012;33:6739–6747.
   PubMed Web of Science ®Google Scholar
• Paul F, Dörr J, Würfel J, et al. Early mitoxantrone‐induced cardiotoxicity in secondary progressive multiple sclerosis. J Neurol Neurosur Ps. 2007;78:198–200.
   PubMed Web of Science ®Google Scholar